Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001085146-19-001968
Filing Date
2019-07-25
Accepted
2019-07-25 11:06:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 JAMES C. ROUMELL enza1_72419.htm SC 13D/A 26815
  Complete submission text file 0001085146-19-001968.txt   28316
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Subject) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: SC 13D/A | Act: 34 | File No.: 005-32878 | Film No.: 19973115
SIC: 8071 Services-Medical Laboratories

Mailing Address 2 WISCONSIN CIR SUITE 640 CHEVY CHASE MD 20815
Business Address 2 WISCONSIN CIR SUITE 640 CHEVY CHASE MD 20815 301-656-8500
Roumell Asset Management, LLC (Filed by) CIK: 0001331693 (see all company filings)

EIN.: 522145132 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SC 13D/A